The Recall Desk
SevereFDA (Drugs)·D-1583-2014·Announced 2014-09-17

Baxter Recalls Sodium Chloride Injection Due to Sterility Concerns

Baxter Healthcare is recalling 157,080 containers of 0.9% Sodium Chloride Injection due to complaints of mold in the overpouch, raising concerns about sterility.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an intravenous product, which poses a significant risk of infection or serious injury.

Plain-English summary

Baxter Healthcare Corporation is recalling 157,080 containers of 0.9% Sodium Chloride Injection, USP, 500 mL, VIAFLEX Plastic Container (NDC 0338-0049-03). The recall is being conducted due to a lack of assurance of sterility, specifically following complaints of mold in the overpouch.

The affected product is identified by Lot #C926642 and Product Code 2B1323N. The product was distributed nationwide. This is an intravenous prescription drug used for medical purposes.

Healthcare providers and consumers should stop using the affected product and contact Baxter Healthcare or their local FDA office for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.

The recalled product

Product
SODIUM CHLORIDE (SODIUM CHLORIDE)
Brand
SODIUM CHLORIDE
Affected units
157,080

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #C926642
  • Product Code: 2B1323N

Distribution

Distributed nationwide across the United States.